• Idera Pharmaceuticals Inc., of Cambridge, Mass., said it raised $7 million in a private placement by issuing 424,242 shares of its convertible preferred stock (convertible into 8,484,840 shares of common stock) and warrants to purchase 8,484,840 shares of common stock.